OncoGenesis
About this raise: OncoGenesis, with a valuation of $40.19 million, is raising funds on StartEngine. The company has developed the technology to help prevent cervical cancer deaths through early detection. OncoGenesis offers an affordable and self-administered test that makes cervical cancer screening accessible to women worldwide. The tests include iPap, CerMark, and Cervi, which are fast, accurate, and affordable and eliminate the need for laboratory processing. Peter Gombrich founded OncoGenesis in August 2008. The current crowdfunding campaign has a minimum target of $123,999.70 and a maximum target of $1.24 million. The campaign proceeds will be used for research and development, inventory, company employment, and working capital.
Investment Overview
Committed : $8,775
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 01/09/2025
- Close Date
- 04/08/2025
$124,000
$1,235,000
$500
Equity - Common
Series A
RegCF
$0.95
$40,193,946
Company & Team
Company
- Year Founded
- 2008
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2C
- Margin
- Medium
- Capital Intensity
- Low
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $626,500
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/08/2025 | StartEngine | $40,193,946 | $8,775 | Equity - Common | Active | RegCF |